Preddator Low-volume Microplate Dispenser Awarded ELRIG Prize
News Jul 10, 2013
Redd&Whyte has announced that its innovative Preddator low-volume microplate dispenser has been awarded the “ELRIG Technology Prize”, which recognizes the most interesting automation seen at the recent ELRIG Robotics and Automation Conference.
The award was voted for by delegates at the ELRIG Robotics and Automation show, in recognition of the fact that the Redd&Whyte Preddator nano dispenser has a unique design that is capable of precisely dispensing a wide range of fluid types and cell suspensions into any microplate format from 96-3456 wells.
The Preddator is an ideal research tool for a wide range of applications including: assay development, protein dispensing, DMSO backfilling, silicon oil deposition and PCR master mix preparation.
The system can be used as a stand-alone system or can be integrated into a range of different automated assay preparation and screening systems.
This award winning version of the Preddator is currently in operation at several of the top 10 pharma companies, where it is being successfully used in compound screening groups where consistency of assay data and reduction in assay costs are critical.
Roger Poole, Managing Director of Redd&Whyte said: “Redd&Whyte is honoured to be chosen for this prestigious ELRIG award. For the Preddator system to be acknowledged for liquid handling innovation alongside products from some of the world’s top automation firms is a great endorsement. This is a competition judged by ELRIG delegates and as such is very valuable recognition of the unique contribution Preddator can make to any compound screening workflow.”
Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the BodyNews
A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.READ MORE
CRISPR Study Reveals Errors in Earlier Cancer ResearchNews
MELK, a protein previously thought to be implicated in cancer, has been shown to be unrelated to the disease.READ MORE
Human Malaria Parasites Grown for the First Time in Dormant FormNews
One of the biggest obstacles to eradicating malaria is a dormant form of the parasite which is resistant to most antimalarial drugs and can reawaken years later, causing disease relapse. Researchers have shown they can grow the dormant parasite in engineered human liver tissue for several weeks, allowing them to closely study how the parasite becomes dormant, what vulnerabilities it may have, and how it springs back to life.READ MORE